Utility of inhaled nitric oxide vasoreactivity challenge in pulmonary hypertension associated with interstitial lung disease
Inhaled NO caused a modest reduction in mPAP and PVR in patients with PH-ILD, but the acute hemodynamic response to inhaled NO was not associated with outcomes or response to inhaled treprostinil therapy.
Authors
- Adriano R. Tonelli (ORCID: https://orcid.org/0000-0002-2321-9545)
- Gaurav Manek
- PURNADEO N PERSAUD
- Samar Farha (ORCID: https://orcid.org/0000-0003-4800-8928)
- Bathmapriya Balakrishnan (ORCID: https://orcid.org/0000-0001-6343-0436)
- Mamta Chhabria (ORCID: https://orcid.org/0000-0002-4297-2487)
- Sravanthi Ennala
Institutions
- Cleveland Clinic (US)
- Mayo Clinic Health System (US)
- UConn Health (US)
- MedStar Health (US)
Publication Details
- Journal
- Annals of the American Thoracic Society
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1513/annalsats.202502-148oc
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00